Dynavax Technologies Corp (DVAX)
11.42
-0.34
(-2.89%)
USD |
NASDAQ |
Apr 24, 16:00
11.42
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies Net Income (TTM): -6.389M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.389M |
| September 30, 2023 | 61.12M |
| June 30, 2023 | 110.64M |
| March 31, 2023 | 235.96M |
| December 31, 2022 | 293.16M |
| September 30, 2022 | 325.20M |
| June 30, 2022 | 232.96M |
| March 31, 2022 | 108.68M |
| December 31, 2021 | 76.71M |
| September 30, 2021 | -38.53M |
| June 30, 2021 | -5.702M |
| March 31, 2021 | -61.75M |
| December 31, 2020 | -75.24M |
| September 30, 2020 | -96.53M |
| June 30, 2020 | -134.39M |
| March 31, 2020 | -125.52M |
| December 31, 2019 | -152.60M |
| September 30, 2019 | -155.81M |
| June 30, 2019 | -162.88M |
| March 31, 2019 | -159.61M |
| December 31, 2018 | -158.90M |
| September 30, 2018 | -146.35M |
| June 30, 2018 | -127.95M |
| March 31, 2018 | -108.82M |
| December 31, 2017 | -95.15M |
| Date | Value |
|---|---|
| September 30, 2017 | -89.47M |
| June 30, 2017 | -102.04M |
| March 31, 2017 | -110.71M |
| December 31, 2016 | -112.44M |
| September 30, 2016 | -117.56M |
| June 30, 2016 | -113.00M |
| March 31, 2016 | -107.60M |
| December 31, 2015 | -106.79M |
| September 30, 2015 | -102.22M |
| June 30, 2015 | -101.91M |
| March 31, 2015 | -103.10M |
| December 31, 2014 | -90.72M |
| September 30, 2014 | -81.49M |
| June 30, 2014 | -67.35M |
| March 31, 2014 | -59.74M |
| December 31, 2013 | -66.72M |
| September 30, 2013 | -74.21M |
| June 30, 2013 | -76.32M |
| March 31, 2013 | -74.27M |
| December 31, 2012 | -69.95M |
| September 30, 2012 | -53.67M |
| June 30, 2012 | -51.11M |
| March 31, 2012 | -46.64M |
| December 31, 2011 | -48.60M |
| September 30, 2011 | -59.45M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-162.88M
Minimum
Jun 2019
325.20M
Maximum
Sep 2022
22.58M
Average
-6.389M
Median
Dec 2023
Net Income (TTM) Benchmarks
| Supernus Pharmaceuticals Inc | 1.316M |
| Ligand Pharmaceuticals Inc | 52.15M |
| Pacira BioSciences Inc | 41.96M |
| Esperion Therapeutics Inc | -209.25M |
| PetIQ Inc | 2.131M |